BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7000133)

  • 1. Effect of purification steps on the immunogenicity of Mycobacterium leprae.
    Shepard CC; Draper P; Rees RJ; Lowe C
    Br J Exp Pathol; 1980 Aug; 61(4):376-9. PubMed ID: 7000133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot pad enlargement as a measure of induced immunity to Mycobacterium leprae.
    Shepard CC; Minagawa F; Van Landingham R; Walker LL
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):371-81. PubMed ID: 7009447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searches among mycobacterial cultures for antileprosy vaccines.
    Shepard CC; van Landingham R; Walker LL
    Infect Immun; 1980 Sep; 29(3):1034-9. PubMed ID: 7000701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
    Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae.
    Gill HK; Mustafa AS; Ivanyi J; Harboe M; Godal T
    Lepr Rev; 1986 Dec; 57 Suppl 2():293-300. PubMed ID: 3553802
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress in the preparation of an antileprosy vaccine from armadillo-derived Mycobacterium leprae.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):515-8. PubMed ID: 6368415
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of purification and fluorescent staining on viability of Mycobacterium leprae.
    Lahiri R; Randhawa B; Krahenbuhl JL
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):194-202. PubMed ID: 16830641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine triphosphate content of Mycobacterium leprae: effect of purification procedures.
    Dhople AM; Storrs EE
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):83-9. PubMed ID: 7042615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological potential of a cultivable mycobacterial strain M. habana against leprosy bacillus in mouse foot pad.
    Singh NB; Srivastava ; Gupta HP; Sreevatsa ; Desikan KV
    Indian J Lepr; 1985; 57(2):278-81. PubMed ID: 3908575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of Mycobacterium leprae to dapsone: alteration by purification procedures.
    Prabhakaran K; Harris EB; Kirchheimer WF
    Lepr India; 1981 Apr; 53(2):160-2. PubMed ID: 6789004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research in leprosy. A report of a committee set up by the medical research council to study future prospects.
    Clin Exp Immunol; 1979 Apr; 36(1):1-7. PubMed ID: 380853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat stability of Mycobacterium leprae immunogenicity.
    Shepard CC; Walker LL; van Landingham R
    Infect Immun; 1978 Oct; 22(1):87-93. PubMed ID: 365752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.
    Shepard CC; van Landingham RM; Walker LL; Ye SZ
    Infect Immun; 1983 Jun; 40(3):1096-103. PubMed ID: 6343239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.
    Smelt AH; Liew FY; Rees RJ
    Clin Exp Immunol; 1978 Nov; 34(2):164-9. PubMed ID: 367652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of monitoring antibodies to PGL-I in armadillos experimentally infected with M. leprae.
    Truman RW; Morales MJ; Shannon EJ; Hastings RC
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):556-9. PubMed ID: 3546545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naive armadillos.
    Pena M; Geluk A; Van Der Ploeg-Van Schip JJ; Franken KL; Sharma R; Truman R
    Lepr Rev; 2011 Dec; 82(4):422-31. PubMed ID: 22439281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
    Bapat CV
    Acta Leprol; 1984; 2(2-4):175-94. PubMed ID: 6442820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine from ICRC bacilli against M. leprae infection in mouse foot-pad.
    Bhide MB; Pradhan KS; Bapat CV
    Lepr India; 1978 Jul; 50(3):334-44. PubMed ID: 359922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.